Q BioMed Inc. (QBIO)

Q BioMed Balance Sheet

Financials in millions USD. Fiscal year is December - November.

Year	2022	2021	2020	2019	2018
Cash & Equivalents	0.05	0.34	0.18	0.17	2.68
Cash & Cash Equivalents	0.05	0.34	0.18	0.17	2.68
Cash Growth	-85.47%	94.20%	2.61%	-93.57%	225.47%
Receivables	0.01	0.08	0	0	0
Inventory	-0	0.02	0	0	0
Other Current Assets	0.01	0.01	0.05	0.02	0.01
Total Current Assets	0.07	0.46	0.22	0.19	2.7
Long-Term Investments	3.14	0	0	0	0
Intangible Assets	0.3	0.35	0.4	0.45	0.5
Total Long-Term Assets	3.44	0.35	0.4	0.45	0.5
Total Assets	3.52	0.81	0.62	0.64	3.2
Accounts Payable	2.13	1.35	0.72	0.65	0.39
Current Debt	4.11	3.05	0.09	3.24	0
Other Current Liabilities	1.89	1.1	0.89	1.34	0.04
Total Current Liabilities	8.13	5.49	1.7	5.24	0.43
Long-Term Debt	0	0	0	0.45	2.87
Other Long-Term Liabilities	-0	0	0	0	0
Total Long-Term Liabilities	-0	0	0	0.45	2.87
Total Liabilities	8.13	5.49	1.7	5.69	3.3
Total Debt	4.11	3.05	0.09	3.69	2.87
Debt Growth	34.62%	3211.86%	-97.50%	28.45%	-
Common Stock	0.08	0.03	0.02	0.02	0.01
Retained Earnings	-66.1	-64.13	-55.89	-42.39	-32.11
Comprehensive Income	0	-0	0	0	0
Shareholders' Equity	-4.62	-4.69	-1.08	-5.05	-0.11
Total Liabilities and Equity	3.52	0.81	0.62	0.64	3.2
Net Cash / Debt	-4.06	-2.71	0.08	-3.52	-0.19
Net Cash Per Share	-0.09	-0.10	0.00	-0.23	-0.01
Working Capital	-8.06	-5.04	-1.48	-5.05	2.27
Book Value Per Share	-0.10	-0.17	-0.05	-0.34	-0.01

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.